Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−19.71 USD
263.07 K USD
0.00 USD
1.02 M
About Silexion Therapeutics Corp
Silexion Therapeutics Corp. engages in the discovery and development of treatments for KRAS-driven cancers. The company is headquartered in Modiin, Israel.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SLXN is 2.44 USD — it has increased by 0.83% in the past 24 hours. Watch Silexion Therapeutics Corp stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Silexion Therapeutics Corp stocks are traded under the ticker SLXN.
SLXN stock has fallen by −21.04% compared to the previous week, the month change is a −27.99% fall, over the last year Silexion Therapeutics Corp has showed a −97.51% decrease.
We've gathered analysts' opinions on Silexion Therapeutics Corp future price: according to them, SLXN price has a max estimate of 9.00 USD and a min estimate of 9.00 USD. Watch SLXN chart and read a more detailed Silexion Therapeutics Corp stock forecast: see what analysts think of Silexion Therapeutics Corp and suggest that you do with its stocks.
SLXN reached its all-time high on Aug 7, 2024 with the price of 122.02 USD, and its all-time low was 1.86 USD and was reached on Nov 15, 2024. View more price dynamics on SLXN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SLXN stock is 21.23% volatile and has beta coefficient of 0.99. Track Silexion Therapeutics Corp stock price on the chart and check out the list of the most volatile stocks — is Silexion Therapeutics Corp there?
Today Silexion Therapeutics Corp has the market capitalization of 3.91 M, it has decreased by −16.67% over the last week.
Yes, you can track Silexion Therapeutics Corp financials in yearly and quarterly reports right on TradingView.
Silexion Therapeutics Corp is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
SLXN earnings for the last quarter are −7.40 USD per share, whereas the estimation was −7.38 USD resulting in a −0.27% surprise. The estimated earnings for the next quarter are −0.98 USD per share. See more details about Silexion Therapeutics Corp earnings.
SLXN net income for the last quarter is −11.86 M USD, while the quarter before that showed −110.58 K USD of net income which accounts for −10.63 K% change. Track more Silexion Therapeutics Corp financial stats to get the full picture.
No, SLXN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SLXN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Silexion Therapeutics Corp stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Silexion Therapeutics Corp technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Silexion Therapeutics Corp stock shows the sell signal. See more of Silexion Therapeutics Corp technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.